Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.

Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Poduslo JF. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. J Pharmacol Exp Ther. 2005 Jun; 313(3):1370-8.

View in: PubMed

subject areas

Alzheimer Disease
Amyloid beta-Protein Precursor
Animals
Biological Transport
Blood-Brain Barrier
Brain
Humans
Iodine Radioisotopes
Membrane Proteins
Mice
Mice, Inbred C57BL
Mice, Transgenic
Peptide Fragments
Presenilin-1

authors with profiles

Karunya Kandimalla

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support